“…Candidate yeast oral vaccines with cell surface display are being developed against a diverse array of pathogens, including White Spot Syndrome Virus, H5N1 Influenza A Virus, African Swine Fever Virus, and SARS-CoV2, among others, that infect a wide range of animal organisms including shrimp, fish, fowl, swine, and human beings ( Table 1 ). Most of these yeast oral vaccines use the a-agglutinin Aga1p-Aga2p Yeast Surface Display (YSD) system in S. cerevisiae ( Mei et al, 2017 ; Zhang C. et al, 2022 ). Here, the heterologous protein of interest, in our case, the candidate antigen/immunogen, is expressed as a fusion to the Aga2p protein, which in vivo is linked to cell-wall covalently-associated Aga1p through two disulfide bonds.…”